Anzeige
Mehr »
Login
Montag, 30.09.2024 Börsentäglich über 12.000 News von 692 internationalen Medien
Aktuelle News: Größter Player im Valley der 1.000%-er!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
178 Leser
Artikel bewerten:
(1)

Fourier Co. Ltd.: Fourier Unveils the Next-Generation Humanoid Robot GR-2

SHANGHAI, Sept. 30, 2024 /PRNewswire/ -- Fourier, the Shanghai-based robotics company, announces the launch of GR-2, the latest addition to its GRx humanoid robot series. With remarkable upgrades across hardware, design, and software, GR-2 marks a new milestone in the field of humanoid robotics.

Fourier GR-2

Next-Level Hardware Design

GR-2 builds upon the success of its predecessor, GR-1 - the world's first mass-produced humanoid robot. Standing at 175 cm and weighing 63 kg, GR-2 offers 53 degrees of freedom and a single-arm load capacity of 3 kg, enabling it to tackle more complex tasks.

The new robot features a detachable battery with the capacity doubled, extending runtime by an hour. This upgrade boosts GR-2's adaptability, making it capable of handling a broader range of challenges, such as long-distance walking.

Engineering Breakthroughs for Developers

GR-2 features integrated cabling design for power and communication transmission, allowing concealed wires and more compact packaging. The efficient layout optimizes space for easier modularization and greater adaptiveness for application-oriented customization.

To simplify the control system and reduce maintenance, Fourier re-designed GR-2's joint configuration, shifting from a parallel to a serial structure. It improves debugging, lowers manufacturing costs, and enhances the robot's ability to rapidly learn and transition from AI simulation to real-world applications.

12-Degrees-of-Freedom Dexterous Hands: Precision in Motion

GR-2 introduces 12-DoF dexterous hands-double the dexterity of previous models. Designed to mirror the flexibility of human physiology, these hands adapt seamlessly to complex tasks with greater precision.

The 12-Degree-of-Freedom Dexterous Hand is equipped with 6 array-type tactile sensors, enabling GR-2 to adapt seamlessly to complex tasks with greater precision.

Equipped with six array-type tactile sensors, GR-2 can sense force, identify object shapes and materials, and adjust its grip in real time for optimal manipulation in dynamic settings.

Supporting multiple upper-limb teaching modes-VR remote control, lead-through programming, and direct command-GR-2 can record a comprehensive set of operational data, from motion paths to tactile responses. The robust data collection expects to bridge the gap between virtual models and real-world applications, pushing the boundaries of robot training and deployment further.

FSA 2.0: Powering Dynamic Mobility

Fourier breaks new ground in humanoid robotics by incorporating human-like motion into GR-2's design. To optimize its movement, the company developed seven distinct FSA actuators for GR-2, each tailored to meet the specific torque demands of every joint.

FSA 2.0 Actuators series include seven different types of actuators, allowing each to tailored to meet the specific torque demands of GR-2's every joint.

With peak torques exceeding 380 N.m, FSA 2.0 boosts GR-2's agility and dynamic capabilities. The dual-encoder system doubles control accuracy, ensuring precise movements even in high-pressure environments. Designed for both speed and precision, FSA 2.0 empowers GR-2 to navigate complex tasks with greater flexibility.

Optimized Tools for Innovative Development

Fourier prioritizes the developer's experience. The company optimized GR-2's development platform by introducing a new software development kit compatible with mainstream programming languages such as ROS. Developers can have easy access to a robust suite of pre-optimized modules for machine vision, path planning, and force feedback control through intuitive APIs.

Supporting frameworks such as NVIDIA Isaac Lab and Mujoco, the new platform empowers developers to focus on innovation, streamlining their workflow and elevating the robotics development experience.

"GR-2 is a big step into the future of humanoid robotics," said Alex Gu, CEO of Fourier. "We're passionate about building the most intuitive embodied agent for AI, allowing it to engage with the physical world in ways like never before. Fourier is excited to have developers, researchers, and enterprises join us on this incredible journey."

Fourier GRx series outlines six key areas for humanoid robotics development-locomotion, manipulation, cognition, bionic design, user experience, and commercial viability.

Fourier GRx series sets new standards in humanoid robotics with its emphasis on AI integration. In view of the future evolution of humanoid robot entities, the company outlines six key areas for development-locomotion, manipulation, cognition, bionic design, user experience, and commercial viability. The launch of GR-2 marks a new step toward future breakthroughs in human-robot collaboration.

About Fourier

Founded in 2015, Fourier is a leading general-purpose robotics company. At Fourier, our mission is to leverage full-stack robotics technology to enrich people's lives. We're headquartered in Shanghai, China with a team of over 500 employees globally. For more information about Fourier, please visit: www.fftai.com.

Photo - https://mma.prnewswire.com/media/2518296/GR_2.jpg
Photo - https://mma.prnewswire.com/media/2518297/GR_2__________1.jpg
Photo - https://mma.prnewswire.com/media/2518298/FSA_Actuators.jpg
Photo - https://mma.prnewswire.com/media/2518299/Fourier_GRx_Series.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/fourier-unveils-the-next-generation-humanoid-robot-gr-2-302262432.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.